NDC 0944-2814

Aralast NP

Alpha-1-proteinase Inhibitor (human)

Aralast NP is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta U.s. Inc.. The primary component is .

Product ID0944-2814_25476011-16db-4de7-b1f8-191a193aae00
NDC0944-2814
Product TypePlasma Derivative
Proprietary NameAralast NP
Generic NameAlpha-1-proteinase Inhibitor (human)
Dosage FormKit
Marketing Start Date2002-12-23
Marketing CategoryBLA / BLA
Application NumberBLA125039
Labeler NameBaxalta U.S. Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0944-2814-01

1 KIT in 1 CARTON (0944-2814-01) * 25 mL in 1 VIAL (0944-2803-03) * 25 mL in 1 VIAL, GLASS
Marketing Start Date2002-12-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0944-2814-01 [00944281401]

ARALAST NP KIT
Marketing CategoryBLA
Application NumberBLA125039
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2002-12-23

Drug Details

NDC Crossover Matching brand name "Aralast NP" or generic name "Alpha-1-proteinase Inhibitor (human)"

NDCBrand NameGeneric Name
0944-2814AralastAlpha-1-Proteinase Inhibitor (Human)
0944-2815AralastAlpha-1-Proteinase Inhibitor (Human)
13533-700PROLASTIN-CALPHA-1-PROTEINASE INHIBITOR (HUMAN)
13533-703PROLASTIN-CALPHA-1-PROTEINASE INHIBITOR (HUMAN)
13533-706PROLASTIN-CALPHA-1-PROTEINASE INHIBITOR (HUMAN)

Trademark Results [Aralast]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ARALAST
ARALAST
76419771 2976973 Live/Registered
BAXALTA INCORPORATED
2002-06-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.